This is the authors' abstract. We don't add key points for this paper.
Primary progressive multiple sclerosis (MS) has long been recognised as presenting great difficulties to our management of what is increasingly a treatable neurological disease. Here we review some basic and clinical aspects of primary progressive MS, and describe how the disorder in fact offers powerful insights and opportunities for better understanding multiple sclerosis, and from a practical perspective an invaluable clinical substrate for studying and treating progressive disability in MS. Difficult hurdles remain, however, and these too are reviewed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rice et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: